Literature DB >> 22264550

Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.

Bertrand Janne d'Othée1, Constantinos T Sofocleous, Nader Hanna, Robert J Lewandowski, Michael C Soulen, Jean-Nicolas Vauthey, Steven J Cohen, Alan P Venook, Matthew S Johnson, Andrew S Kennedy, Ravi Murthy, Jean-Francois Geschwind, Stephen T Kee.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22264550      PMCID： PMC4352314          DOI： 10.1016/j.jvir.2011.12.003

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  94 in total

1.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.

Authors:  J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

2.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

3.  Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Authors:  S Giacchetti; B Perpoint; R Zidani; N Le Bail; R Faggiuolo; C Focan; P Chollet; J F Llory; Y Letourneau; B Coudert; F Bertheaut-Cvitkovic; D Larregain-Fournier; A Le Rol; S Walter; R Adam; J L Misset; F Lévi
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 4.  Surgical therapy of hepatic colorectal metastasis.

Authors:  Y Fong
Journal:  CA Cancer J Clin       Date:  1999 Jul-Aug       Impact factor: 508.702

5.  Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer.

Authors:  Ronnie Tp Poon; Nicholas Borys
Journal:  Future Oncol       Date:  2011-08       Impact factor: 3.404

6.  The use of 3-D dose volume analysis to predict radiation hepatitis.

Authors:  T S Lawrence; R K Ten Haken; M L Kessler; J M Robertson; J T Lyman; M L Lavigne; M B Brown; D J DuRoss; J C Andrews; W D Ensminger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

7.  Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

Authors:  Hyuk Hur; Yong Taek Ko; Byung Soh Min; Kyung Sik Kim; Jin Sub Choi; Seung Kook Sohn; Chang Hwan Cho; Heung Kyu Ko; Jong Tai Lee; Nam Kyu Kim
Journal:  Am J Surg       Date:  2008-09-11       Impact factor: 2.565

8.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

9.  Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.

Authors:  Yoji Kishi; Eddie K Abdalla; Yun Shin Chun; Daria Zorzi; David C Madoff; Michael J Wallace; Steven A Curley; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

10.  Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

Authors:  Nancy E Kemeny; Fidel D Huitzil Melendez; Marinela Capanu; Philip B Paty; Yuman Fong; Lawrence H Schwartz; William R Jarnagin; Dina Patel; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544
View more
  6 in total

1.  Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

Authors:  Constantinos T Sofocleous; Elena G Violari; Vlasios S Sotirchos; Waleed Shady; Mithat Gonen; Neeta Pandit-Taskar; Elena N Petre; Lynn A Brody; William Alago; Richard K Do; Michael I D'Angelica; Joseph R Osborne; Neil H Segal; Jorge A Carrasquillo; Nancy E Kemeny
Journal:  Clin Colorectal Cancer       Date:  2015-06-27       Impact factor: 4.481

2.  Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

Authors:  Waleed Shady; Sirish Kishore; Somali Gavane; Richard K Do; Joseph R Osborne; Gary A Ulaner; Mithat Gonen; Etay Ziv; Franz E Boas; Constantinos T Sofocleous
Journal:  Eur J Radiol       Date:  2016-03-31       Impact factor: 3.528

3.  Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Rüdiger Schernthaner; David Lesage; Zhijun Wang; Lynn Jeanette Savic; Jean-François Geschwind
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

4.  Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model.

Authors:  Luke R Wilkins; Hanping Wu; John R Haaga; Agata Exner
Journal:  J Vasc Interv Radiol       Date:  2012-04-14       Impact factor: 3.464

5.  Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.

Authors:  Waleed Shady; Vlasios S Sotirchos; Richard K Do; Neeta Pandit-Taskar; Jorge A Carrasquillo; Mithat Gonen; Constantinos T Sofocleous
Journal:  AJR Am J Roentgenol       Date:  2016-07-06       Impact factor: 3.959

Review 6.  Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.

Authors:  Giovanni Mauri; Lorenzo Monfardini; Andrea Garnero; Maria Giulia Zampino; Franco Orsi; Paolo Della Vigna; Guido Bonomo; Gianluca Maria Varano; Marco Busso; Carlo Gazzera; Paolo Fonio; Andrea Veltri; Marco Calandri
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.